{"id":42217,"date":"2023-11-05T00:22:09","date_gmt":"2023-11-05T00:22:09","guid":{"rendered":"https:\/\/innodebt.com\/investing\/mirati-gets-mhra-approval-for-krazati-to-treat-non-small-cell-lung-cancer-patients\/"},"modified":"2023-11-05T00:22:11","modified_gmt":"2023-11-05T00:22:11","slug":"mirati-gets-mhra-approval-for-krazati-to-treat-non-small-cell-lung-cancer-patients","status":"publish","type":"post","link":"https:\/\/innodebt.com\/?p=42217","title":{"rendered":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20231103-710134\" role=\"document\">\n<p>By Stephen Nakrosis<\/p>\n<pre><\/pre>\n<p>Mirati Therapeutics said on Friday the U.K.&#8217;s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval for Krazati to treat certain non-small cell lung cancer patients.<\/p>\n<div class=\"paywall\">\n<p>Krazati was given approval as a treatment for adult patients who have &#8220;advanced non-small cell lung cancer with KRAS(G12C) mutation and have progressive disease after prior therapy with, or intolerance to, platinum-based chemotherapy and\/or anti-PD-1\/PD-L1 immunotherapy,&#8221; the company said.<\/p>\n<p>In December, Krazati received approval from the Food and Drug Administration as a treatment for certain adult patients with non-small cell lung cancer.<\/p>\n<p>The biotechnology company said lung cancer is one of the most common cancers worldwide.<\/p>\n<pre><\/pre>\n<p>Write to Stephen Nakrosis at stephen.nakrosis@wsj.com<\/p>\n<pre><\/pre>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/mirati-gets-mhra-approval-for-krazati-to-treat-non-small-cell-lung-cancer-patients-477f15c8?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.&#8217;s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval for Krazati to treat certain non-small cell lung cancer patients. Krazati was given approval as a treatment for adult patients who have &#8220;advanced non-small cell lung cancer with KRAS(G12C) mutation and have progressive disease after [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3704,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[32],"tags":[],"class_list":{"0":"post-42217","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt<\/title>\n<meta name=\"description\" content=\"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.&#039;s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innodebt.com\/?p=42217\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt\" \/>\n<meta property=\"og:description\" content=\"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.&#039;s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innodebt.com\/?p=42217\" \/>\n<meta property=\"og:site_name\" content=\"Innodebt\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-05T00:22:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-05T00:22:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/innodebt.com\/?p=42217#article\",\"isPartOf\":{\"@id\":\"https:\/\/innodebt.com\/?p=42217\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/innodebt.com\/#\/schema\/person\/742362d9a293429cc45829acf21919b4\"},\"headline\":\"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients\",\"datePublished\":\"2023-11-05T00:22:09+00:00\",\"dateModified\":\"2023-11-05T00:22:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/innodebt.com\/?p=42217\"},\"wordCount\":139,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/innodebt.com\/#organization\"},\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/innodebt.com\/?p=42217#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innodebt.com\/?p=42217\",\"url\":\"https:\/\/innodebt.com\/?p=42217\",\"name\":\"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt\",\"isPartOf\":{\"@id\":\"https:\/\/innodebt.com\/#website\"},\"datePublished\":\"2023-11-05T00:22:09+00:00\",\"dateModified\":\"2023-11-05T00:22:11+00:00\",\"description\":\"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.'s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval\",\"breadcrumb\":{\"@id\":\"https:\/\/innodebt.com\/?p=42217#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innodebt.com\/?p=42217\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innodebt.com\/?p=42217#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innodebt.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innodebt.com\/#website\",\"url\":\"https:\/\/innodebt.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/innodebt.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innodebt.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/innodebt.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/innodebt.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/innodebt.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/innodebt.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/innodebt.com\/#\/schema\/person\/742362d9a293429cc45829acf21919b4\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/innodebt.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/innodebt.com\"],\"url\":\"https:\/\/innodebt.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt","description":"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.'s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innodebt.com\/?p=42217","og_locale":"en_US","og_type":"article","og_title":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt","og_description":"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.'s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval","og_url":"https:\/\/innodebt.com\/?p=42217","og_site_name":"Innodebt","article_published_time":"2023-11-05T00:22:09+00:00","article_modified_time":"2023-11-05T00:22:11+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/innodebt.com\/?p=42217#article","isPartOf":{"@id":"https:\/\/innodebt.com\/?p=42217"},"author":{"name":"News Room","@id":"https:\/\/innodebt.com\/#\/schema\/person\/742362d9a293429cc45829acf21919b4"},"headline":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients","datePublished":"2023-11-05T00:22:09+00:00","dateModified":"2023-11-05T00:22:11+00:00","mainEntityOfPage":{"@id":"https:\/\/innodebt.com\/?p=42217"},"wordCount":139,"commentCount":0,"publisher":{"@id":"https:\/\/innodebt.com\/#organization"},"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/innodebt.com\/?p=42217#respond"]}]},{"@type":"WebPage","@id":"https:\/\/innodebt.com\/?p=42217","url":"https:\/\/innodebt.com\/?p=42217","name":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients | Innodebt","isPartOf":{"@id":"https:\/\/innodebt.com\/#website"},"datePublished":"2023-11-05T00:22:09+00:00","dateModified":"2023-11-05T00:22:11+00:00","description":"By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.'s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval","breadcrumb":{"@id":"https:\/\/innodebt.com\/?p=42217#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innodebt.com\/?p=42217"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/innodebt.com\/?p=42217#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innodebt.com\/"},{"@type":"ListItem","position":2,"name":"Mirati Gets MHRA Approval for Krazati to Treat Non-Small Cell Lung Cancer Patients"}]},{"@type":"WebSite","@id":"https:\/\/innodebt.com\/#website","url":"https:\/\/innodebt.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/innodebt.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innodebt.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/innodebt.com\/#organization","name":"Funding Factories","url":"https:\/\/innodebt.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/innodebt.com\/#\/schema\/logo\/image\/","url":"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/innodebt.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/innodebt.com\/#\/schema\/person\/742362d9a293429cc45829acf21919b4","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/innodebt.com\/#\/schema\/person\/image\/","url":"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/innodebt.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/innodebt.com"],"url":"https:\/\/innodebt.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/posts\/42217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/innodebt.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42217"}],"version-history":[{"count":1,"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/posts\/42217\/revisions"}],"predecessor-version":[{"id":42218,"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/posts\/42217\/revisions\/42218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innodebt.com\/index.php?rest_route=\/wp\/v2\/media\/3704"}],"wp:attachment":[{"href":"https:\/\/innodebt.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/innodebt.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/innodebt.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}